Trademark: 86045285
Word

Status
Dead
Status Code
710
Status Date
Friday, November 19, 2021
Serial Number
86045285
Registration Number
4729961
Registration Date
Tuesday, May 5, 2015
Mark Type
2000
Filing Date
Thursday, August 22, 2013
Published for Opposition
Tuesday, February 17, 2015
Cancellation Date
Friday, November 19, 2021

Trademark Owner History
Vernalis (R&D) Limited - Original Registrant

Classifications
5 Pharmaceutical and veterinary preparations for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders; Sanitary preparations for medical purposes; Dietetic food and substances for medical or veterinary use in the nature of pasta, breads, cereals, crackers, meat, fruit, vegetables, confectionery, lipids in the nature of margarine, butter substitute, lard, fish oil, butter, peanut oil, soya bean oil, sunflower oil, sesame oil, coconut oil, olive oil, animal-derived fats and oils, plant-derived oils and dairy products in the nature of cheese, milk, butter, yoghurt, cream, and curds, all adapted for medical use; dietary supplements for humans and animals; chemical reagents for medical or veterinary purposes; chemical medical reagents for therapeutic and diagnostic purposes; chemico-pharmaceutical preparations for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders; medical chemical preparations for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders; medicines for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders
42 Scientific and technological services, namely, pharmaceutical product evaluation, development and testing services; industrial analysis and research services in the nature of pharmaceutical product evaluation, development and testing services; biotechnology research; chemical research; research consulting in the field of pharmaceutical product evaluation, development and testing services; scientific, medical and clinical research and development in the nature of pharmaceutical product evaluation, development and testing services; research and development in the nature of pharmaceutical product evaluation, development and testing services; laboratory research services relating to pharmaceuticals; pharmaceutical research; medical and scientific laboratory services; laboratory testing services in the field of pharmaceutical product evaluation, development and testing services; testing of pharmaceuticals; chemical analysis; technological research in the nature of pharmaceutical product evaluation, development and testing services; conducting product evaluations in the field of new pharmaceuticals; inspection of pharmaceuticals; pharmaceutical product evaluation; pharmaceutical drug development services; information, advisory and consultancy services relating to all the aforesaid services
Color is not claimed as a feature of the mark.
The mark consists of one smaller crescent shape inside of a larger crescent shape.

Trademark Events
Nov 19, 2021
Cancelled Sec. 8 (6-Yr)
May 5, 2020
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
May 5, 2015
Registered-Principal Register
Feb 17, 2015
Official Gazette Publication Confirmation E-Mailed
Feb 17, 2015
Published For Opposition
Jan 28, 2015
Notification Of Notice Of Publication E-Mailed
Jan 12, 2015
Law Office Publication Review Completed
Jan 12, 2015
Approved For Pub - Principal Register
Jan 12, 2015
Examiner's Amendment Entered
Jan 12, 2015
Notification Of Examiners Amendment E-Mailed
Jan 12, 2015
Examiners Amendment E-Mailed
Jan 12, 2015
Examiners Amendment -Written
Jan 8, 2015
Notification Of Non-Final Action E-Mailed
Jan 8, 2015
Non-Final Action E-Mailed
Jan 8, 2015
Non-Final Action Written
Jan 2, 2015
Previous Allowance Count Withdrawn
Dec 16, 2014
Withdrawn From Pub - Og Review Query
Dec 4, 2014
Law Office Publication Review Completed
Dec 1, 2014
Approved For Pub - Principal Register
Nov 26, 2014
Examiner's Amendment Entered
Nov 26, 2014
Notification Of Examiners Amendment E-Mailed
Nov 26, 2014
Examiners Amendment E-Mailed
Nov 26, 2014
Examiners Amendment -Written
Nov 8, 2014
Teas/Email Correspondence Entered
Nov 7, 2014
Correspondence Received In Law Office
Nov 7, 2014
Teas Response To Office Action Received
Nov 7, 2014
Teas Response To Office Action Received
May 8, 2014
Notification Of Non-Final Action E-Mailed
May 8, 2014
Non-Final Action E-Mailed
May 8, 2014
Non-Final Action Written
May 6, 2014
Teas/Email Correspondence Entered
May 6, 2014
Correspondence Received In Law Office
Apr 25, 2014
Assigned To Lie
Apr 8, 2014
Teas Change Of Correspondence Received
Apr 8, 2014
Teas Response To Office Action Received
Oct 28, 2013
Notification Of Non-Final Action E-Mailed
Oct 28, 2013
Non-Final Action E-Mailed
Oct 28, 2013
Non-Final Action Written
Oct 28, 2013
Assigned To Examiner
Oct 1, 2013
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 1, 2013
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 31, 2013
Notice Of Design Search Code E-Mailed
Aug 30, 2013
New Application Office Supplied Data Entered In Tram
Aug 26, 2013
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24